FindTrial
Sign In

Ayurvedic Pharmacovigilance study

Adverse drug reaction monitoring of Ayurvedic medicine in Ayurvedic setup hospital to determine the patterns of ADR - A Pharmacovigilance study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2010/091/001164
Enrollment
250
Registered
2010-08-18
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- A prospective, observational study was conducted over a period of 1 year

Interventions

Intervention1: No intervention: day 1 to 45days. Control Intervention1: Nil: Nil

Sponsors

No sponsorship
Lead Sponsor
No Secondary sponsor
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: All OPD and IPD patients of KLE Ayurveda hospital, presenting with the ADR (as per WHO definition)

Exclusion criteria

Exclusion criteria: Patients with intentional and accidental poisoning will be excluded

Design outcomes

Primary

MeasureTime frame
vomiting, nausea, diarrhea, rashes, fewer etc.Timepoint: immediate, 30mins, 1hour, 6hour, upto 45days—

Secondary

MeasureTime frame
Chronic drug eventsTimepoint: up to 6-months—

Countries

India

Contacts

Public ContactDrManjunath Ajanal

KLEUs BMK Ayurveda medical college Belgaum

manju.ajanal@gmail.com09036616510

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026